Ngā hua rapu - J.-P. Devogelaer
- E whakaatu ana i te 1 - 17 hua o te 17
-
1
-
2
Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion G... mā Y. Boutsen, Jacques Jamart, W. Esselinckx, J.-P. Devogelaer
I whakaputaina 2001Artigo -
3
-
4
Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of t... mā P. Bergmann, J.J. Body, Steven Boonen, Y. Boutsen, J. P. Devogelaer, Stefan Goemaere, Jean M. Kaufman, J.-Y. Reginster, Valérie Gangji
I whakaputaina 2008Revisão -
5
Management of osteoporosis in the elderly mā René Rizzoli, Olivier Bruyère, Jorge B. Cannata‐Andía, J. P. Devogelaer, George P. Lyritis, J. D. Ringe, Bruno Vellas, J.-Y. Reginster
I whakaputaina 2009Revisão -
6
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications mā J.J. Body, Pierre Bergmann, Steven Boonen, J.-P. Devogelaer, Evelien Gielen, Stefan Goemaere, Jean‐Marc Kaufman, Serge Rozenberg, J.-Y. Reginster
I whakaputaina 2012Artigo -
7
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club mā J.J. Body, P. Bergmann, Steven Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, Jean‐Marc Kaufman, Serge Rozenberg, J.-Y. Reginster
I whakaputaina 2010Revisão -
8
Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology-Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3-Month Effects on Biomarkers of Bone Turnover mā László B. Tankó, Yu Z. Bagger, Peter Alexandersen, J.-P. Devogelaer, Jean‐Yves Reginster, Rosalind Chick, Melvin Olson, Hakim Benmammar, Linda Mindeholm, M. Azria, Claus Christiansen
I whakaputaina 2004Artigo -
9
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club mā Jean‐Jacques Body, P. Bergmann, S. Boonen, Y. Boutsen, Olivier Bruyère, J.-P. Devogelaer, Stefan Goemaere, Nadine Hollevoet, Jean‐Marc Kaufman, Koen Milisen, Serge Rozenberg, J.-Y. Reginster
I whakaputaina 2011Revisão -
10
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study mā Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul, S. Adámi, Juliet Compston, C. Phenekos, J.-P. Devogelaer, Díaz Curiel M, A. Sawicki, Stefan Goemaere, O. H. Sørensen, Dieter Felsenberg, Pierre J. Meunier
I whakaputaina 2005Artigo -
11
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis mā J-Y. Reginster, J.-M. Kaufman, Stefan Goemaere, J.-P. Devogelaer, C.L. Benhamou, Dieter Felsenberg, Díaz Curiel M, Maria Luisa Brandi, J Badurski, John D. Wark, Á. Balogh, Olivier Bruyère, Christian Roux
I whakaputaina 2011Artigo -
12
Management of Glucocorticoid-Induced Osteoporosis mā René Rizzoli, Jonathan D. Adachi, Cyrus Cooper, W. Dere, J. P. Devogelaer, Adolfo Díez‐Pérez, John А. Kanis, Andrea Laslop, Bruce Mitlak, Socrates E. Papapoulos, SH Ralston, S. Reiter, G. Werhya, Jean‐Yves Reginster
I whakaputaina 2012Revisão -
13
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections abou... mā J.-Y. Reginster, S Reiter-Niesert, Olivier Bruyère, Françis Berenbaum, Maria Luisa Brandi, Jaime Branco, J.-P. Devogelaer, Gabriel Herrero‐Beaumont, John А. Kanis, Stefania Maggi, E. Maheu, Pascal Richette, René Rizzoli, Cyrus Cooper
I whakaputaina 2015Revisão -
14
Treatment of osteoporosis in men mā JM Kaufman, J.-Y. Reginster, Steven Boonen, Maria Luisa Brandi, Cyrus Cooper, W. Dere, J.-P. Devogelaer, Adolfo Díez‐Pérez, John А. Kanis, E. McCloskey, Bruce Mitlak, Eric Orwoll, J. D. Ringe, G. Weryha, René Rizzoli
I whakaputaina 2012Revisão -
15
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis mā Éric Abadie, D Ethgen, Bernard Avouac, G Bouvenot, Jaime Branco, Olivier Bruyère, Gonzalo Calvo, J.-P. Devogelaer, R.-L. Dreiser, Gabriel Herrero‐Beaumont, André Kahan, G. Kreutz, Andrea Laslop, Ernst Martin Lemmel, George Nuki, Leo van de Putte, L. Vanhaelst, Jean‐Yves Reginster
I whakaputaina 2004Revisão -
16
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis mā Robin Altman, Éric Abadie, Bernard Avouac, G Bouvenot, Jaime Branco, Olivier Bruyère, Gonzalo Calvo, J.-P. Devogelaer, R.-L. Dreiser, Gabriel Herrero‐Beaumont, André Kahan, G. Kreutz, Andrea Laslop, Ernst Martin Lemmel, C J Menkès, Karel Pavelká, Leo van de Putte, L. Vanhaelst, Jean‐Yves Reginster
I whakaputaina 2004Revisão -
17
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density mā Ian R. Reid, Jacques P. Brown, P. Burckhardt, Zebulun D. Horowitz, Peter Richardson, U. Trechsel, A. Widmer, J.-P. Devogelaer, Jean‐Marc Kaufman, Philippe Jaeger, Jean-Jacques Body, Maria Luisa Brandi, Johann Broell, Raffaele Di Micco, Andrea Riccardo Genazzani, Dieter Felsenberg, J. Happ, Michael Hooper, Jochen Ittner, G. Leb, Hans Mallmin, Timothy M. Murray, S. Ortolani, Alessandro Rubinacci, Maria Sääf, Göran Samsioe, Leon Verbruggen, Pierre J. Meunier
I whakaputaina 2002Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Osteoporosis
Alternative medicine
Intensive care medicine
Pathology
Bone mineral
Physical therapy
Bone remodeling
Strontium ranelate
Surgery
Bisphosphonate
Clinical trial
Computer science
Endocrinology
Environmental health
Osteoarthritis
Placebo
Population
Vitamin D and neurology
Bone density
Bone mass
Bone resorption
Calcium
Chemistry
Evidence-based medicine
FRAX
Glucocorticoid
Law
Osteoporotic fracture